KIRA-7
CAS No. : 1937235-76-1
| Size | Price | Stock |
|---|---|---|
| 5mg | $410 | In-stock |
| 10mg | $670 | In-stock |
| 25mg | $1340 | In-stock |
| 50mg | $2150 | In-stock |
| 100mg | $3500 | In-stock |
| 200 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-124646 |
| M.Wt: | 466.51 |
| Formula: | C27H23FN6O |
| Purity: | >98 % |
| Solubility: | DMSO : 100 mg/mL (ultrasonic) |
KIRA-7, an imidazopyrazine compound, binds the IRE1α kinase (IC50 of 110 nM) to allosterically inhibit its RNase activity. KIRA-7 has an anti-fibrotic effect[1]. IC50 & Target:IC50: 110 nM (IRE1α kinase)[1] In Vitro: KIRA-7 can inhibit XBP1 splicing in the alveolar epithelial cell line MLE12[1]. In Vivo: KIRA-7 (5 mg/kg; intraperitoneal injection; daily for 14 days; C57BL6 mice) treatment results in decreased spliced XBP1 and ATF4, compared to bleomycin exposed mice treated with vehicle. Likewise, mRNA levels of BiP and CHOP are significantly elevated after Bleomycin exposure, and treatment of Bleomycin-exposed mice with KIRA-7 decreased these levels. mRNA levels of collagen 1A1 and fibronectin are both significantly decreased by KIRA-7 treatment[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information- Product Name:
- KIRA-7
- Cat. No.:
- HY-124646
- Quantity:
Your information is safe with us.